BeBetter Med (SHSE:688759) FCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688759 BeBetter Med Inc SHSE:688759
4 GF Score
Price ¥23.20
View Full Analysis

What is BeBetter Med FCF Margin %?

BeBetter Med SHSE:688759 -17.26% 4 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates SHSE:688759 with a GF Score™ of 4/100. Among 950 Biotechnology companies, BeBetter Med ranks worse than 105263.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BeBetter Med's Free Cash Flow for the three months ended in Mar. 2026 was ¥-63.46 Mil. BeBetter Med's Revenue for the three months ended in Mar. 2026 was ¥0.00 Mil. Therefore, BeBetter Med's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, BeBetter Med's current FCF Yield % is -1.48%.

The historical rank and industry rank for BeBetter Med's FCF Margin % or its related term are showing as below:


During the past 7 years, the highest FCF Margin % of BeBetter Med was -1674.29%. The lowest was -11293.63%. And the median was -11006.19%.

SHSE:688759's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -82.715
* Ranked among companies with meaningful FCF Margin % only.


BeBetter Med FCF Margin % Related Terms


BeBetter Med FCF Margin % Historical Data

* Premium members only.

The historical data trend for BeBetter Med's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BeBetter Med FCF Margin % Chart

BeBetter Med Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -11,006.19 0.00 0.00 0.00 0.00

BeBetter Med Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SHSE:688759 vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, BeBetter Med's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeBetter Med FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeBetter Med's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BeBetter Med's FCF Margin % falls into.


SHSE:688759
4GF Score
BeBetter Med Inc SHSE:688759
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BeBetter Med FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BeBetter Med's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-113.15/0
= %

BeBetter Med's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-63.464/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
BeBetter Med (SHSE:688759) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BeBetter Med and its competitors. According to the industry distribution chart, BeBetter Med ranks #999999 out of 950 companies in the Biotechnology industry.
Is BeBetter Med's FCF Margin % too high?
BeBetter Med's current FCF Margin % is 0.00%. Based on the distribution chart, BeBetter Med ranks #999999 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BeBetter Med has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does BeBetter Med's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BeBetter Med ranks #999999 out of 950 companies for FCF Margin %. This places BeBetter Med in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BeBetter Med and its competitors. BeBetter Med's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BeBetter Med stock overvalued right now?
BeBetter Med (SHSE:688759) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. BeBetter Med's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BeBetter Med (SHSE:688759), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BeBetter Med Business Description

Address No. 25 Yayingshi Road, Room 802, 8th Floor, Building A-3, Science City, High-tech Industrial Development Zone, Guangzhou, Guangdong, CHN, 510663
BeBetter Med Inc is a biopharmaceutical company based in China, focusing on independent research and development of drugs. The company focuses on developing novel medicines for treating cancers, autoimmune diseases, and other severe conditions. Key products include the PI3K/HDAC dual inhibitor BEBT-908 and multiple drugs in clinical trial phases targeting cancers. It's a United States subsidiary BeBetter Pharma specializes in next-generation siRNA therapeutics using proprietary delivery platforms aimed at complex diseases like kidney disorders, metabolic and liver diseases, and neurodegenerative conditions. Its pipeline includes oral and injectable drug candidates, some in late-stage trials, and aims to address unmet medical needs through novel mechanisms.
4GF Score

Get the complete analysis for SHSE:688759

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.20
Price